TCF7L2 and type 2 diabetes mellitus: Since 2006, intensive genome-wide association studies (GWAS) have revealed that TCF7L2 is among the type 2 diabetes risk genes,7, 8 while the expression of dominant negative TCF7L2 (TCF7L2DN) was shown to stimulate adipogenesis.4